Sonoma Pharmaceuticals, Inc. Shares of Common Stock (par value, $0.0001 per share) EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 18th, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), with the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”, on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
